<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37195112</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1660-9379</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>827</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Revue medicale suisse</Title><ISOAbbreviation>Rev Med Suisse</ISOAbbreviation></Journal><ArticleTitle>[Long COVID : neurological aspects].</ArticleTitle><Pagination><StartPage>972</StartPage><EndPage>974</EndPage><MedlinePgn>972-974</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.53738/REVMED.2023.19.827.972</ELocationID><Abstract><AbstractText>The study of post-COVID-19 symptomatology revealed a first wave of post-acute (persistence of symptoms less than 3 months) neurocognitive symptoms. However, some of these symptoms worsened, while others improved. To our knowledge, these symptoms may persist for up to 1 to 2 years after infection. The intensity, variability and persistence of neurocognitive symptoms may rise the hypotheses of accelerated neurodegenerative processes, as well as neuropsychiatric and/or genetic vulnerabilities that are still poorly understood. Moreover, the multi-organ manifestations of post-COVID-19 symptoms remind us of the importance of promoting an interdisciplinary perspective at both clinical and fundamental levels. Finally, many social and economic issues parallel to the neuropathological consequences remain to be investigated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nuber-Champier</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de neuropsychologie clinique et exp&#xe9;rimentale, Facult&#xe9; de psychologie et des sciences de l'&#xe9;ducation, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit&#xe9; de neurologie cognitive, Service de neurologie, H&#xf4;pitaux universitaires de Gen&#xe8;ve, 1211 Gen&#xe8;ve 14.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voruz</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratoire de neuropsychologie clinique et exp&#xe9;rimentale, Facult&#xe9; de psychologie et des sciences de l'&#xe9;ducation, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit&#xe9; de neurologie cognitive, Service de neurologie, H&#xf4;pitaux universitaires de Gen&#xe8;ve, 1211 Gen&#xe8;ve 14.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de m&#xe9;decine, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cionca</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de neuropsychologie clinique et exp&#xe9;rimentale, Facult&#xe9; de psychologie et des sciences de l'&#xe9;ducation, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacot De Alc&#xe2;ntara</LastName><ForeName>Isabele</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratoire de neuropsychologie clinique et exp&#xe9;rimentale, Facult&#xe9; de psychologie et des sciences de l'&#xe9;ducation, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;ron</LastName><ForeName>Julie Anne</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Laboratoire de neuropsychologie clinique et exp&#xe9;rimentale, Facult&#xe9; de psychologie et des sciences de l'&#xe9;ducation, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit&#xe9; de neurologie cognitive, Service de neurologie, H&#xf4;pitaux universitaires de Gen&#xe8;ve, 1211 Gen&#xe8;ve 14.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assal</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de neurologie cognitive, Service de neurologie, H&#xf4;pitaux universitaires de Gen&#xe8;ve, 1211 Gen&#xe8;ve 14.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de m&#xe9;decine, Universit&#xe9; de Gen&#xe8;ve, 1211 Gen&#xe8;ve 4.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Covid long : aspects neurologiques.</VernacularTitle></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Rev Med Suisse</MedlineTA><NlmUniqueID>101219148</NlmUniqueID><ISSNLinking>1660-9379</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058025" MajorTopicYN="N">Interdisciplinary Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019359" MajorTopicYN="N">Knowledge</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>L&#x2019;&#xe9;tude de la symptomatologie post-Covid-19 a permis de mettre en &#xe9;vidence une premi&#xe8;re vague de sympt&#xf4;mes neurocognitifs postaigus (persistance des sympt&#xf4;mes inf&#xe9;rieurs &#xe0; 3 mois). Certains se sont aggrav&#xe9;s, tandis que d&#x2019;autres se sont am&#xe9;lior&#xe9;s. Ils peuvent perdurer jusqu&#x2019;&#xe0; 1 &#xe0; 2 ans apr&#xe8;s l&#x2019;infection. L&#x2019;intensit&#xe9;, la variabilit&#xe9; et la persistance des sympt&#xf4;mes neurocognitifs pourraient sugg&#xe9;rer des hypoth&#xe8;ses d&#x2019;acc&#xe9;l&#xe9;ration de processus neurod&#xe9;g&#xe9;n&#xe9;ratifs et des vuln&#xe9;rabilit&#xe9;s neuropsychiatriques et/ou g&#xe9;n&#xe9;tiques encore mal comprises. De plus, les manifestations multi-organiques des sympt&#xf4;mes post-Covid-19 nous rappellent l&#x2019;importance de promouvoir une perspective multidisciplinaire sur les plans clinique et fondamental. Finalement, de nombreuses questions sociales et &#xe9;conomiques parall&#xe8;les aux cons&#xe9;quences neuropathologiques restent &#xe0; investiguer.</AbstractText></OtherAbstract><CoiStatement>Les auteurs n&#x2019;ont d&#xe9;clar&#xe9; aucun conflit d&#x2019;int&#xe9;r&#xea;ts en relation avec cet article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37195112</ArticleId><ArticleId IdType="doi">10.53738/REVMED.2023.19.827.972</ArticleId><ArticleId IdType="pii">RMS0827-009</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>